Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia

Bibliographische Detailangaben
Hauptverfasser:	Boultwood, J, Perry, J, Pellagatti, A, Giagounidis, A, Malcovati, L, Della Porta, MG, Jaedersten, M, Killick, S, Hellstroem-Lindberg, E, Cazzola, M, Wainscoat, J
Format:	Conference item
Veröffentlicht:	2009

Ähnliche Einträge

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
von: Boultwood, J, et al.
Veröffentlicht: (2010)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
von: Fernandez-Mercado, M, et al.
Veröffentlicht: (2010)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
von: Pellagatti, A, et al.
Veröffentlicht: (2008)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
von: Pellagatti, A, et al.
Veröffentlicht: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
von: Pellagatti, A, et al.
Veröffentlicht: (2010)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
von: Pellagatti, A, et al.
Veröffentlicht: (2009)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
von: Pellagatti, A, et al.
Veröffentlicht: (2010)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
von: Pellagatti, A, et al.
Veröffentlicht: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
von: Pellagatti, A, et al.
Veröffentlicht: (2011)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
von: Pellagatti, A, et al.
Veröffentlicht: (2010)

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)
von: Pellagati, A, et al.
Veröffentlicht: (2008)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
von: Pellagatti, A, et al.
Veröffentlicht: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
von: Pellagatti, A, et al.
Veröffentlicht: (2005)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
von: Pellagatti, A, et al.
Veröffentlicht: (2006)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
von: Pellagatti, A, et al.
Veröffentlicht: (2007)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
von: Pellagatti, A, et al.
Veröffentlicht: (2013)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
von: Pellagatti, A, et al.
Veröffentlicht: (2009)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
von: Pellagatti, A, et al.
Veröffentlicht: (2008)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
von: Pellagatti, A, et al.
Veröffentlicht: (2006)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
von: Wang, L, et al.
Veröffentlicht: (2007)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
von: Wang, L, et al.
Veröffentlicht: (2008)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
von: Boultwood, J, et al.
Veröffentlicht: (2007)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
von: Pellagatti, A, et al.
Veröffentlicht: (2014)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
von: Boultwood, J, et al.
Veröffentlicht: (2004)

Gene expression profiling in the myelodysplastic syndromes.
von: Pellagatti, A, et al.
Veröffentlicht: (2005)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
von: Boultwood, J, et al.
Veröffentlicht: (2008)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridization (CGH).
von: Esoof, N, et al.
Veröffentlicht: (2006)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
von: Pellagatti, A, et al.
Veröffentlicht: (2004)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays
von: Li Wang, et al.
Veröffentlicht: (2008-07-01)

Differential expression of genes related to JAK-STAT pathway activation or megakaryocyte differentiation/maturation in CD34+cells from patients with refractory anemia with ringed sideroblasts and thrombocytosis (RARS-T)
von: Malcovati, L, et al.
Veröffentlicht: (2007)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
von: Pellagatti, A, et al.
Veröffentlicht: (2017)

Clonality in the myelodysplastic syndromes.
von: Boultwood, J, et al.
Veröffentlicht: (2001)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
von: Fernandez-Mercado, M, et al.
Veröffentlicht: (2013)

Molecular pathogenesis of the myelodysplastic syndromes
von: Boultwood, J, et al.
Veröffentlicht: (1999)

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
von: Boultwood, J, et al.
Veröffentlicht: (2010)

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
von: Boultwood, J, et al.
Veröffentlicht: (2010)

Gene expression profiling of day 7 erythroblasts from RARS before and after treatment with G-CSF
von: Nikpour, M, et al.
Veröffentlicht: (2007)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
von: Malcovati, L, et al.
Veröffentlicht: (2011)

Myelodysplastic/myeloproliferative disorders
von: Luca Malcovati, et al.
Veröffentlicht: (2008-01-01)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells
von: Davies, C, et al.
Veröffentlicht: (2013)